Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2025CancersOpen Access

The Role of Genomic Scores in the Management of Prostate Cancer Patients: A Comprehensive Narrative Review

View Full Paper
Ask AI
Bookmark
Share

Authors

AVAlessandro VitiLQLeonardo QuartaPZPaolo Zaurito

Discussion

Loading...

Member takes

Overview

Narrative review highlights genomic scores' role in risk stratification and personalized treatment for prostate cancer.

Key Points

  • Genomic scores are key tools in managing prostate cancer, enhancing risk stratification and treatment decisions.
  • Polygenic risk scores estimate individual susceptibility to prostate cancer from genetic variants, aiding early detection.
  • Tumor-derived genomic classifiers provide prognostic information, influencing eligibility for therapies like active surveillance.
  • Integrating genomic scores with clinical factors can improve personalized care for prostate cancer patients.

Cite This Study

Viti et al. (2025) studied this question.

synapsesocial.com/papers/689a02bce6551bb0af8cc733https://doi.org/10.3390/cancers17142334
View Full Paper
Ask AI
Bookmark
Share